Universal Health Realty Income | 10-Q: FY2025 Q3 Revenue: USD 25.3 M

Revenue: As of FY2025 Q3, the actual value is USD 25.3 M.

EPS: As of FY2025 Q3, the actual value is USD 0.29.

EBIT: As of FY2025 Q3, the actual value is USD 8.832 M.

Segment Revenue

• Lease Revenue - UHS Facilities: $8,367,000 for the three months ended September 30, 2025, compared to $8,248,000 for the same period in 2024. For the nine months ended September 30, 2025, lease revenue was $25,075,000 compared to $25,366,000 in 2024.
• Lease Revenue - Non-related Parties: $14,777,000 for the three months ended September 30, 2025, compared to $14,342,000 for the same period in 2024. For the nine months ended September 30, 2025, lease revenue was $43,676,000 compared to $43,188,000 in 2024.

Operational Metrics

• Net Income: $4,016,000 for the three months ended September 30, 2025, compared to $3,997,000 for the same period in 2024. For the nine months ended September 30, 2025, net income was $13,285,000 compared to $14,573,000 in 2024.
• Depreciation and Amortization: $7,903,000 for the three months ended September 30, 2025, compared to $7,009,000 for the same period in 2024. For the nine months ended September 30, 2025, it was $21,742,000 compared to $20,624,000 in 2024.

Cash Flow

• Net Cash Provided by Operating Activities: $35,495,000 for the nine months ended September 30, 2025, compared to $33,758,000 for the same period in 2024.
• Net Cash Used in Investing Activities: - $12,433,000 for the nine months ended September 30, 2025, compared to - $11,164,000 in 2024.
• Net Cash Used in Financing Activities: - $23,243,000 for the nine months ended September 30, 2025, compared to - $24,434,000 in 2024.

Unique Metrics

• Equity in Income of Unconsolidated LLCs: $438,000 for the three months ended September 30, 2025, compared to $300,000 for the same period in 2024. For the nine months ended September 30, 2025, it was $1,215,000 compared to $956,000 in 2024.

Future Outlook and Strategy

• Core Business Focus: The company plans to continue investing in healthcare and human-service related facilities, with a focus on maintaining and expanding its portfolio of medical office buildings and hospital facilities. The company is also engaged in the development of new properties, such as the Palm Beach Gardens Medical Plaza I, which is expected to be completed in the third quarter of 2026.
• Non-Core Business: The company is actively managing its portfolio by divesting lower-performing properties and reinvesting the proceeds into new developments or acquisitions that meet its planned rate of return.